You are here

  • Home
  • Archive
  • Volume 25, Issue 8
  • Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?

Article info

Article menu
Download PDFPDF
Uterine Cancer
Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?

Authors

  • Chunyan Lan Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; and PubMed articlesGoogle scholar articles
  • Xin Huang Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; and PubMed articlesGoogle scholar articles
  • Qidan Huang Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; and PubMed articlesGoogle scholar articles
  • Yin Wang Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; and PubMed articlesGoogle scholar articles
  • Haifeng Gu Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; and PubMed articlesGoogle scholar articles
  • Yong Li Department of Pathology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. PubMed articlesGoogle scholar articles
  • Jihong Liu Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, China; and PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Jihong Liu, MD, PhD, Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, 651 Dongfeng Rd East, Guangzhou 510060, China. Email: liujh@sysucc.org.cn.

Citation

Lan C, Huang X, Huang Q, et al
Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?
International Journal of Gynecologic Cancer 2015;25:1445-1452.

Publication history

  • Received July 11, 2015
  • First published October 1, 2015.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2015 by IGCS and ESGO